Enhancing Market Access for Fibroscan, a Novel Diagnostic Device
This case study examines how Policy Reporter supported Echosens in enhancing market access for FibroScan, a novel diagnostic device for assessing liver health. FibroScan provides immediate, non-invasive results, making it a valuable alternative to traditional diagnostic methods like MRIs and blood tests. Policy Reporter collaborated with Echosens to address market access challenges, including restrictive payer policies, claim denials, and coverage variability. Through tools such as PolicyCore, Policy Reporter enabled Echosens to streamline payer engagement, educate providers, and optimize reimbursement strategies. These efforts significantly improved workflow efficiency and expanded FibroScan's adoption, ultimately benefiting patient care and outcomes.
Enhancing Market Access for Fibroscan, a Novel Diagnostic Device
Please submit the form below to view this resource.
Request Access
Please fill out the form below to access our Industry Resources.
By submitting this form, you agree to our use of this information for the purpose of contacting you. For more information, please refer to our privacy policy.